RE:RE:RE:RE:Any positive news and thisLooks like Copy-paste to me from 2013 news.
Only concerns about progress they have had made since Sep 2013-still doing pilot program as announced in this news release, what have been changed since then? only stock price which went down!!!!!!!
Read this as well and compare:
Miraculins’ SCOUT DS® Non-Invasive Diabetes Screening Test to be piloted by Major Cdn Supermarket September 16, 2013
Miraculins’ SCOUT DS® Non-Invasive Diabetes Screening Test
to be piloted by Major Canadian Supermarket Chain
New Test Conducted without Blood Draw or Fasting to be featured
in Pharmacy Diabetes Clinics at 35 Store Locations in fall 2013
WINNIPEG, Manitoba – September 16, 2013 - Miraculins Inc. (TSX-V:MOM), (”Miraculins” or the “Company”) a medical diagnostic company focused on acquiring, developing and commercializing diagnostic and risk assessment technologies for unmet clinical needs, today announces that a major Canadian supermarket chain, in collaboration with Pear Healthcare Solutions (“Pear”), a leading provider of in-pharmacy health screening and educational services to the Canadian pharmacy community, will be conducting a special pilot of the Miraculins’ SCOUT DS® Non-Invasive Diabetes Screening technology as part of a series of pharmacy diabetes clinics to be held at 35 store locations in fall 2013.
The SCOUT DS® is a ground-breaking technology that non-invasively measures changes in the composition of a person's skin indicative of pre-diabetes and type 2 diabetes. It is a painless, user-friendly test that takes 90 seconds and provides immediate results. Unlike current screening methods a SCOUT DS® test requires no needle, blood draw or fasting, and no waiting for a lab result. The technology has been used and validated in thousands of patients around the world.
“Major retailers can help Canadians live healthy lifestyles not just by providing fresh food and healthy product offerings, but by partnering with healthcare companies like Pear to provide customers with in-pharmacy disease screening and prevention programs,” says Paul Moreau, Vice President Sales & Marketing for Miraculins Inc. “Pre-diabetes and type 2 diabetes are life-threatening conditions that are at epidemic proportions in our country and there are more than 6,000 retail, brand-name pharmacies across the country that could potentially incorporate SCOUT DS® screening into their risk assessment services, to educate millions of Canadians about diabetes awareness and help those most at risk get the assistance they need.”
The fall clinics will be conducted to help retail customers learn more about their risk of diabetes, and its effects and complications, along with the best ways to control it through dietary modification, physical activity, ongoing monitoring and other healthcare applications and approaches. A patient whose SCOUT DS® screening result suggests a likelihood of pre-diabetes or type 2 diabetes will be recommended to see their doctor to have a diagnostic blood test done (Oral Glucose Tolerance Test or an HbA1c Test) to make a diagnosis.
This programming is a major step forward in the commercialization of the Miraculins’ SCOUT DS® in the Canadian retail pharmacy segment. Pilots like this allow pharmacies to introduce this new technology to their customersand to learn how to maximize the in-store potential of this exciting new screening test. After the pilot phase is successfully completed, this lays the groundwork for the potential expansion of the SCOUT DS® across all stores within the chain. Beyond this specific application, Miraculins and Pear are working to establish additional pilots in multiple retail chains with the objective of having the SCOUT DS® available to millions of Canadians in thousands of pharmacies.
Additional information about the SCOUT DS® pilots will be made available on conclusion of the current programming.